Evidence map›Paper›PMID 29085325›Full record

ReviewFrontiers in neurology2017

The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders.

Javier Mateo, Olivia Esteban, Mireya Martínez, Andrzej Grzybowski, Francisco Javier Ascaso

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Update on pediatric optic neuritis.Current opinion in ophthalmology · 2019
    Review
  5. Article
  6. Review
  7. Review
  8. Neuro-Ophthalmology at the Bedside: A Clinical Guide.Journal of neurosciences in rural practice
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Javier MateoDepartment of Ophthalmology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Olivia EstebanDepartment of Ophthalmology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Mireya MartínezDepartment of Ophthalmology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Andrzej GrzybowskiDepartment of Ophthalmology, Poznan City Hospital, Poznan, Poland.
Francisco Javier AscasoDepartment of Ophthalmology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain.
Hospital Clínico Universitario Lozano Blesa · ESUniversity of Warmia and Mazury in Olsztyn · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) comprises a group of central nervous system disorders of inflammatory autoimmune origin that mainly affect the optic nerves and the spinal cord and can cause severe visual and general disability. The clinical signs are similar to those of multiple sclerosis (MS), with the result that it is often difficult to differentiate between the two, thus leading to misdiagnosis. As the treatment and prognosis of NMOSD and MS are different, it is important to make an accurate and early diagnosis of NMOSD. Optical coherence tomography (OCT) is a non-invasive technique that enables a quantitative study of the changes that the optic nerve and the macula undergo in several neurodegenerative diseases. Many studies have shown that some of these changes, such as retinal nerve fiber layer thinning or microcystic macular edema, can be related to alterations in the brain due to neurodegenerative disorders. The purpose of this mini-review is to show how OCT can be useful for the diagnosis of NMOSD and follow-up of affected patients, as well as for the differential diagnosis with MS.

Indexed as

autoimmune diseasesDevic diseasemultiple sclerosisneuromyelitis opticaoptical coherence tomographyoptic neuritis

Identifiers

PMID29085325
PMCPMC5649178
OpenAlexW2756777913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.